Hobro, Denmark

Jacob Mathiesen




Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Jacob Mathiesen

Introduction

Jacob Mathiesen is a notable inventor based in Hobro, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of particulate materials for solid dosage forms. With a total of two patents to his name, Mathiesen's work focuses on enhancing the efficacy and usability of therapeutic compounds.

Latest Patents

Mathiesen's latest patents include a particulate material comprising a calcium-containing compound and a sugar alcohol. This invention relates to a solid dosage form, notably tablets, that utilize a regularly shaped calcium-containing compound, such as a calcium salt, as a therapeutically and/or prophylactically active substance. The formulation also includes a pharmaceutically acceptable sugar alcohol, such as sorbitol or isomalt, which exhibits a microstructure as evidenced by scanning electron microscopy (SEM). The process for preparing this particulate material involves agglomeration through roller compaction, making it suitable for further processing into tablets, including chewing tablets.

Career Highlights

Jacob Mathiesen is currently employed at Takeda A/S, where he continues to innovate in the pharmaceutical sector. His work has contributed to advancements in drug formulation and delivery systems, enhancing patient care and treatment options.

Collaborations

Mathiesen has collaborated with notable colleagues, including Carsten Martini Nielsen and Peder Mohr Olsen, to further his research and development efforts in the pharmaceutical industry.

Conclusion

Jacob Mathiesen's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving therapeutic formulations. His work continues to impact the industry positively, paving the way for future advancements in drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…